Survival after T-Cell Replete Haploidentical Related Donor Transplant Using Post-Transplant Cyclophosphamide Compared with Matched Unrelated Donor ( MUD) Transplant for Lymphoid Malignancies

被引：0

作者：

Mussetti, Alberto ^{[1
]}

Kanate, Abraham Sebastian ^{[2
,3
]}

Kharfan-Dabaja, Mohamed A. ^{[4
]}

Ahn, Kwang Woo ^{[5
]}

DiGilio, Alyssa ^{[5
]}

Ciurea, Stefan O. ^{[6
]}

Armand, Philippe ^{[7
]}

Salit, Rachel B. ^{[8
]}

Fenske, Timothy S. ^{[9
]}

Smith, Sonali M. ^{[10
]}

Sureda, Anna ^{[11
]}

Bolanos-Meade, Javier ^{[12
]}

Hamadani, Mehdi ^{[13
]}

机构：

[1] Inst Nazl Tumori, SC Ematol & Trapianto Midollo Osseo, Milan, Italy

[2] W Virginia Univ, Osborn Hematopoiet Malignancy & Transplantat Prog, Sect Hematol & Oncol, Morgantown, WV 26506 USA

[3] W Virginia Univ, Dept Med, Morgantown, WV 26506 USA

[4] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat, Tampa, FL 33612 USA

[5] Med Coll Wisconsin, CIBMTR, Dept Med, Milwaukee, WI 53226 USA

[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[7] Dana Farber Canc Inst, Boston, MA 02115 USA

[8] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA

[9] Med Coll Wisconsin, Div Hematolgy & Oncol, Milwaukee, WI 53226 USA

[10] Univ Chicago, Chicago, IL 60637 USA

[11] Hosp Duran & Reynals, Inst Catala Oncol, Barcelona, Spain

[12] Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Baltimore, MD USA

[13] Med Coll Wisconsin, CIBMTR, Div Med, Milwaukee, WI 53226 USA

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[31] HAPLOIDENTICAL T-REPLETE TRANSPLANT WITH POST-TRANSPLANT HIGH DOSE CYCLOPHOSPHAMIDE (PT-HDCY) IN PATIENTS OLDER THAN 60 YEARS: EARLY OUCOMES COMPARED TO HLA MATCHED RELATED (MRD) OR UNRELATED (MUD) TRANSPLANTS
Blaise, D.
Castagna, L.
Fuerst, S.
Crocchiolo, R.
Devillier, R.
Bramanti, S.
El Cheikh, J.
Granata, A.
Sarina, B.
Harbi, S.
Mohty, B.
Lemarie, C.
Chabannon, C.
Santorro, A.
[J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S230 - S230
[32] Comparison of Haploidentical Hematopoietic Stem Cell Transplantation Utilizing Post-Transplant Cyclophosphamide in Children with Hematological Malignancies to Matched Sibling and Matched Unrelated Donor Bone Marrow Allografts
Srinivasan, A.
Kung, R.
Gabura, S.
Raffa, E.
Chopra, Y.
Schechter-Finkelstein, T.
Ali, M.
Chiang, K. -Y.
Krueger, J.
[J]. PEDIATRIC BLOOD & CANCER, 2021, 68 : S93 - S93
[33] T-cell replete haploidentical transplantation with reduced post-transplant cyclophosphamide in six children with infantile osteopetrosis
Al-Seraihy, Amal
Al-Saedi, Hawazen
Al-Ahmari, Ali
Ghemlas, Ibrahim
Ayas, Mouhab
[J]. BONE MARROW TRANSPLANTATION, 2021, 56 (07) : 1757 - 1760
[34] Enhanced Immunosuppression in T-Cell Replete Haploidentical Transplantation With Post-Transplant Cyclophosphamide is Associated With Favorable Outcomes
Bousiou, Zoi
Sakellari, Ioanna
Varelas, Christos
Testa, Theodolinda
Mallouri, Despoina
Batsis, Ioannis
Gavriilaki, Eleni
Douka, Vassiliki
Papalexandri, Apostolia
Papadopoulou, Anastasia
Koukoulias, Kiriakos
Sotiropoulos, Damianos
Papaemmanouil, Styliani
Geroukis, Triantaffilos
Fouka, Evangelia
Fylaktou, Asimina
Giannouzakos, Vasileios
Yannaki, Evangelia
Anagnostopoulos, Achilles
[J]. BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 209 - 210
[35] T-cell replete haploidentical transplantation with reduced post-transplant cyclophosphamide in six children with infantile osteopetrosis
Amal Al-Seraihy
Hawazen Al-Saedi
Ali Al-Ahmari
Ibrahim Ghemlas
Mouhab Ayas
[J]. Bone Marrow Transplantation, 2021, 56 : 1757 - 1760
[36] T-Cell Replete Haploidentical Bone Marrow Transplantation and Post-Transplant Cyclophosphamide for Patients with Inborn Errors
Albert, Michael H.
Kurzay, Mathias
Schmid, Irene
Feuchtinger, Tobias
Hauck, Fabian
Klein, Christoph
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S212 - S212
[37] T-cell replete haploidentical bone marrow transplantation and post-transplant cyclophosphamide for patients with inborn errors
Kurzay, Mathias
Hauck, Fabian
Schmid, Irene
Wiebking, Volker
Eichinger, Anna
Jung, Eva
Boekstegers, Ann
Feuchtinger, Tobias
Klein, Christoph
Albert, Michael H.
[J]. HAEMATOLOGICA, 2019, 104 (10) : E478 - E482
[38] Post-Transplant Cyclophosphamide for Gvhd Prophylaxis in Matched Unrelated Donor Transplantation Compared to ATG-Based Prophylaxis
Bailen, Rebeca
Kwon, Mi
Jesus Pascual-Cascon, Maria
Torrent, Anna
Ferra, Christelle M.
Sanz, Jaime
Doblas-Marquez, Alberto
Benitez, Olga
Pinana Sanchez, Jose Luis
Oarbeascoa, Gillen
Dorado, Nieves
Cristina, Munoz
Martinez-Laperche, Carolina
Anguita, Javier
Buno, Ismael
Luis Diez-Martin, Jose
[J]. BLOOD, 2019, 134
[39] Reduced Post-Transplant Cyclophosphamide Doses in T-Cell Replete Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients with Hematologic Malignancies
Dulery, Remy
Goudet, Claire
Bianchessi, Antonio
Granata, Angela
Harbi, Samia
Maisano, Valerio
Chabannon, Christian
Malard, Florent
Brissot, Eolia
Sestili, Simona
Mediavilla, Clemence
Banet, Anne
Van de Wyngaert, Zoe
Paviglianiti, Annalisa
Belhocine, Ramdane
Ederhy, Stephane
Pagliardini, Thomas
Legrand, Faezeh
Castagna, Lucas
Blaise, Didier
Mohty, Mohamad
Furst, Sabine
Devillier, Raynier
[J]. BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 138 - 139
[40] Favorable Immune Reconstitution After Nonmyeloablative, T-Cell Replete, HLA-Haploidentical BMT with Post-Transplant Cyclophosphamide
Symons, Heather J.
Kesserwan, Chimene
Kos, Ferdynand
Thoburn, Christopher J.
Munchel, Ashley T.
Ying, Wendy
Luznik, Leo
Levitsky, Hyam I.
Jones, Richard J.
Hess, Allan D.
Fuchs, Ephraim J.
[J]. BLOOD, 2011, 118 (21) : 461 - 462

← 1 2 3 4 5 →